Aneta Kowal

Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease

Irena Porębska, Aneta Kowal, Adam Ząbek et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 111 citations

Advanced Lung Disease, Metabolomic Profiling, Pathology +9

Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome

Adam Ząbek, I. Stanimirova, Stanisław Deja et al. · Metabolomics · 2015 · 44 citations · Full text

Genetic polymorphisms and expression of <scp>HLA</scp>‐G and its receptors, <scp>KIR2DL4</scp> and <scp>LILRB1</scp>, in non‐small cell lung cancer

Andrzej Wiśniewski, Aneta Kowal, Ewa Wyrodek et al. · Tissue Antigens · 2015 · 35 citations

Single Nucleotide Polymorphisms of the ERAP1 Gene and Risk of NSCLC: A Comparison of Genetically Distant Populations, Chinese and Caucasian

Yufeng Yao, Andrzej Wiśniewski, Qiangli Ma et al. · Archivum Immunologiae et Therapiae Experimentalis · 2016 · 30 citations · Full text

Histocompatibility, Erap1-nsclc Associations, Genetics +22

Galectin-3 and cyclin D1 expression in non-small cell lung cancer

Monika Kosacka, Paweł Piesiak, Aneta Kowal et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 26 citations · Full text